dalteparin has been researched along with Anuria in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Anuria: Absence of urine formation. It is usually associated with complete bilateral ureteral (URETER) obstruction, complete lower urinary tract obstruction, or unilateral ureteral obstruction when a solitary kidney is present.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneiter, S | 1 |
| Huynh-Do, U | 1 |
| Heizmann, M | 1 |
1 other study available for dalteparin and Anuria
| Article | Year |
|---|---|
[Bleeding complication due to accumulation of low-molecular-weight heparin in a patient with renal insufficiency].
Topics: Acute Kidney Injury; Adolescent; Age Factors; Aged; Anticoagulants; Anuria; Child; Creatinine; Enoxa | 2007 |